COSCIENS Biopharma Inc.
CSCIF- Exchange
- OTC
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001113423
No open-market purchases or sales by COSCIENS Biopharma Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding COSCIENS Biopharma Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 9 | 1 | 15 | +7 |
| Shares | 16.7K | 2 | 21.0K | +4.31K (+25.8%) |
| Value | $61.9K | $8 | $56.9K | −$5.00K (−8.1%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held COSCIENS Biopharma Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 1,151 | $3.09K | 0.00% |
| Citigroup Inc | 902 | $2.42K | 0.00% |
| UBS Group AG | 686 | $1.90K | 0.00% |
| Morgan Stanley | 400 | $1.11K | 0.00% |
| SBI Securities Co., Ltd. | 165 | $457 | 0.00% |
| BNP Paribas Arbitrage, SA | 100 | $271 | 0.00% |
| Group One Trading, L.P. | 37 | $100 | 0.00% |
| Groupe la Francaise | 1 | $8 | 0.00% |
Sold out (1)
Institutions that held COSCIENS Biopharma Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Danske Bank A/S | 2 | $7 |
Not filed for Q4 2024 yet (1)
Institutions that held COSCIENS Biopharma Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Planning Capital Management Corp | 2 | $8 |